The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -68.01%.However, over the last six months, we can see a stronger performance of -58.60%. Over the last 30 days, the price of JSPR has leaped by -64.50%. And in the last five days, it has surged by 18.34%.
Jasper Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $31.01 on 04/01/24 and a low of $5.25 for the same time frame on 01/17/25.
52-week price history of JSPR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Jasper Therapeutics Inc’s current trading price is -77.94% away from its 52-week high, while its distance from the 52-week low is 30.29%. The stock’s price range during this period has varied between$5.25 and $31.01. The Jasper Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.54 million for the day, a figure considerably higher than their average daily volume of 0.48 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Jasper Therapeutics Inc (JSPR) has experienced a quarterly decline of -67.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 102.61M and boasts a workforce of 45 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 18.06, with a change in price of -13.82. Similarly, Jasper Therapeutics Inc recorded 418,267 in trading volume during the last 100 days, posting a change of -66.88%.
JSPR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for JSPR stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
JSPR Stock Stochastic Average
As of today, Jasper Therapeutics Inc’s raw stochastic average for the last 50 days stands at 7.64%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 9.93%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 7.42% and 6.44%, respectively.
